Explore how paclitaxel and innovative drug delivery systems are changing cancer treatment and improving therapeutic outcomes.

Researchers in Japan have developed a lipocalin-based drug delivery system that dramatically increases the solubility of the anticancer drug paclitaxel and enhances tumour suppression in a breast ...

Sociodemographic Inequities in Telemedicine Use Among US Patients Initiating Treatment in Community Cancer Centers During the Ongoing COVID-19 Pandemic, 2020-2022 Based on our observations, it is ...

The controversy over the use of paclitaxel (PTX) in devices used to treat peripheral artery disease (PAD) has taken roughly half a decade to unwind as regulatory agencies across the globe stand down ...